Peter Schwarz
Overview
Explore the profile of Peter Schwarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
5922
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmedabad declaration: A framework to combat growing epidemic of young-onset type 2 diabetes in Asia
Parikh R, Saboo B, Misra A, Basit A, Aravind S, Bhowmik B, et al.
Diabetes Metab Syndr
. 2025 Mar;
19(2):103205.
PMID: 40054119
Aim: Rising prevalence of Type 2 Diabetes (T2D) among young Asians has emerged as a public health crisis that threatens the long-term health, economic stability, and productivity of nations across...
2.
Mahmood L, Moreno L, Schwarz P, Willems R, Cardon G, Hilal S, et al.
Eur J Pediatr
. 2025 Feb;
184(3):214.
PMID: 40016587
Conclusions: Dietary intake varied by country and obesity degree among European children. Across the six countries, children's diets did not align with food-based dietary guidelines. These findings underscore the need...
3.
Saboo B, Garg S, Bergenstal R, Battelino T, Ceriello A, Choudhary P, et al.
Diabetes Technol Ther
. 2025 Feb;
PMID: 39981664
No abstract available.
4.
Barovic M, Hahn J, Heinrich A, Adhikari T, Schwarz P, Mirtschink P, et al.
Diabetes Care
. 2025 Jan;
48(3):405-415.
PMID: 39746149
Objective: Progression of prediabetes to type 2 diabetes has been associated with β-cell dysfunction, whereas its remission to normoglycemia has been related to improvement of insulin sensitivity. To understand the...
5.
Rodionov R, Jarzebska N, Koay Y, Li M, Kuhn M, Bornstein S, et al.
iScience
. 2024 Dec;
27(12):111366.
PMID: 39660051
There is an unmet need for a biomarker of liver fat. We identified dimethylguanidino valeric acid (DMGV) as a circulating biomarker of liver fat. Here, we assess its two isoforms-symmetric...
6.
Torolvsdottir R, Fossadal E, Schwarz P, Johannesen H
J Med Case Rep
. 2024 Nov;
18(1):552.
PMID: 39543758
Background: Primary hyperparathyroidism is an endocrine disease and a common cause of nonmalignant hypercalcemia, often discovered incidentally in asymptomatic patients. The case reported herein illustrates that significant hormonal imbalances can...
7.
Marina D, Ejersted C, Hommel K, Schwarz P
Arch Endocrinol Metab
. 2024 Nov;
68:e240159.
PMID: 39529985
Zoledronic acid is a widely used bisphosphonate for treating osteoporosis and hypercalcemia related to malignancy. It is also used to prevent bone loss induced by cancer treatment and bone metastases...
8.
Silvestro O, Lund-Jacobsen T, Ferrau F, Blanca E, Catalano A, Sparacino G, et al.
J Endocrinol Invest
. 2024 Nov;
48(3):527-546.
PMID: 39509066
Purpose: scientific literature highlights risk factors linked to the onset of psychopathology in different medical pathological contexts. Acromegaly is a rare condition, particularly noteworthy due to the associated clinical psychological...
9.
Lindholm A, Abrahamsen M, Buch-Larsen K, Marina D, Andersson M, Helge J, et al.
Breast Cancer Res
. 2024 Oct;
26(1):142.
PMID: 39415181
Background: Breast cancer patients have an increased risk of cardiometabolic disease and for many patients, adjuvant therapy causes an altered lipid profile, insulin resistance and inflammation. Previous follow-up studies are...
10.
Clarke B, Khan A, Rubin M, Schwarz P, Vokes T, Shoback D, et al.
J Clin Endocrinol Metab
. 2024 Oct;
PMID: 39376010
Context: Conventional therapy for hypoparathyroidism aims to alleviate symptoms of hypocalcemia but does not address insufficient parathyroid hormone (PTH) levels. Objective: Assess the long-term efficacy and safety of TransCon PTH...